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The Canadian Hypertension Education Program (CHEP) was established in 1999 as a response to the result of a national survey
that showed that a high percentage of Canadians were unaware of having hypertension with only 13% of those treated for hy-
pertension having their blood pressure controlled. The CHEP formulates yearly recommendations based on published evidence.
A repeat survey in 2006 showed that the percentage of treated hypertensive patients with the blood pressure controlled had risen
to 65.7%. Over the ﬁrst decade of the existence of the CHEP, the number of prescriptions for antihypertensive medications had
increased by 84.4% associated with a signiﬁcant greater decline in the yearly mortality from stroke, heart failure and myocardial
infarction and a signiﬁcant decrease in the hospitalization for stroke and heart failure. Therefore, the introduction of the CHEP
and the yearly issue of updated recommendations resulted in a signiﬁcant increase in the awareness, diagnosis and treatment of
hypertension and in a signiﬁcant reduction in stroke and cardiovascular morbidity and mortality. The CHEP model could serve
as a template for its adoption to other regions or countries.
1.Introduction
Hypertension is still a major contributor to mortality world-
wide[1], and it is estimated that there are 970 million hyper-
tensives worldwide and it is predicted to increase to 1.56 bil-
lion in the year 2025 [2]. The risk for a fail or morbid cardi-
ovascular or cerebral vascular event starts at the systolic
blood pressure of 115mmHg and a diastolic blood pressure
of 73mmHg.
Therefore, it is not surprising that hypertension accounts
for about 60% of strokes and 50% of heart failure [3]. Con-
sideringthatloweringofsystolicbloodpressureby10mmHg
and diastolic blood pressure by 5mmHg reduces the relative
risk for a coronary artery event by 23% and a stroke by 40%,
it follows that blood pressure is not optimally diagnosed and
treated.
There can be several reasons for this lack of diagnosing
andpropercontrolofhypertension[4].Themajorfactorsare
patient related, for example, poor adherence to treatments,
physician-related inertia to properly inform the public of the
danger of hypertension and the failure of physicians to dia-
gnose,initiate,andtreatbloodpressuretoachievetherecom-
mended blood pressure goals.
2. The CanadianSituation
A Canadian national survey conducted in Canada from 1985
to 1992 revealed that 45% of individuals were unaware of
their blood pressure condition, 22% were aware of hav-
ing hypertension but remained untreated, 21% were treated
but not controlled, and only 13% had their blood pressure
treated and controlled to target, that is, less than 140/
90mmHg [5]. These results were disappointing particularly
considering the easy access of Canadians to health care, but
the Canadian results were similar to some European coun-
tries although better results were reported from the United
States [6].
As a reaction to these results, the Canadian Hypertension
Society established the Canadian Hypertension Education
Program which issued the ﬁrst recommendations for the2 International Journal of Hypertension
Figure 1: Organization of the Canadian Hypertension Education
Program.
management of hypertension in 1999 [7]. The mandate of
theCanadianHypertensionEducationProgram(CHEP)was
to reduce the burden of cardiovascular disease in Canada
through yearly updating evidence-based recommendations
for the management of hypertension, implement the rec-
ommendations, regularly evaluate and revise the program,
and assess the eﬀect of the recommendations by measuring
patient outcomes.
To fulﬁll these tasks, it required the establishment of a
multidisciplinary structure as outlined in Figure 1 [8].
The CHEP is composed of the evidence-based task force
which annually reviews and updates the recommendations
according to new published information [8].
The implementation task force is responsible for the dis-
semination of the recommendations by members who have
expertise in knowledge translation. Dissemination of infor-
mation includes the yearly publication of the recommenda-
tions in the Canadian Journal of Cardiology which is freely
available to every physician, distributing the recommenda-
tions to every practice, hospitals, public health system, the
pharmaceutical industry, and local small group information
meetings with physicians and nurses. Since public awareness
is key to the success of improvement in hypertension man-
agement, a public education task force has developed infor-
mation material for patients and the public at large through
easy-to-understand pamphlets in several languages, articles
inthelaypress,publicinformationmeetings,andavailability
of a website (http://www.hypertension.ca/)[ 9, 10].
The Outcomes Research Task Force is responsible for
evaluating and monitoring the eﬀect of the CHEP activities
on the public awareness and the management of hyperten-
sionatlarge.Thisisaccomplishedthroughanationalsurveil-
lance system in collaboration with the Public Health Agency
of Canada, the Canadian Institute for Health Research, the
Heart and Stroke Foundation of Canada, the Canadian
Stroke Network, provincial databases, and a number of other
organizations [11]. The data collection includes physical
measures and questionnaire surveys, morbidity and mortal-
ity data for hypertension, cardiovascular complications, and
data on antihypertensive drug prescriptions. Questionnaire
surveys are performed every two years to assess the preva-
lence of hypertension diagnosis and treatment. A national
hypertensionsurveillanceprogramhasbeeninitiatedandhas
producedsomeinitialresults[11].Allthisactivityisov erseen
and directed by the executive and steering committees
(Figure 1). Gradually, a number of scientiﬁc organizations,
health care professionals and public health organizations be-
cameinvolvedintheeﬀorttoimprovehypertensionmanage-
ment in Canada.
3. Effectiveness of the CanadianHypertension
EducationProgram
A national survey which was completed in 1992 showed that
almost 50% of Canadians were unaware of having hyper-
tension, 22% who were diagnosed with hypertension were
not treated, and of those treated, only 13% had their blood
pressure controlled below 140/90mmHg [5]. The survey was
then repeated in 2006 which showed that the proportion of
Canadians who were unaware of hypertension had decreased
to 16.7% and those treated and had their blood pressure
controlled had risen to 65.7% [12]. This improvement was
associated with a signiﬁcant 84.4% increase in the number
of prescriptions for antihypertensive drugs [13–15]. There
was also an increased use of 2 or more antihypertensive
drugs [16]. The largest increase of medications occurred
in thiazide diuretics and ace inhibitors, and the smallest
increase occurred in beta blockers, consistent with the CHEP
recommendations not to usebeta blockers asa ﬁrst-line drug
in patients older than 65 years of age [14, 15]. This was
paralleled with an increase in hypertension-related physician
oﬃce visits [14].
The improvement in the management of hypertension
resulted in a signiﬁcant reduction in cardiovascular events
and stroke [13]. Since the inception of the CHEP in 1999,
there was a signiﬁcant greater yearly reduction in mortality
duetostroke −3%,heartfailure −4.3%,and −2.1%foracute
myocardial infarctions. Similarly, there was also a signiﬁcant
reductioninthenumberofhospitalizationsforstroke −1.6%
and −3.1% for heart failure, but the rate of decline in
hospitalizationforacuteMIremainedunchanged,thereason
for which is not entirely clear. The decrease in mortality
correlatedwiththeincreaseintheprescriptionforantihyper-
tensivedrugs[13].Theaverageyearlyreductionsinmortality
due to heart failure, stroke, and acute MI were signiﬁcantly
greater than for noncardiovascular disease deaths or cancer
[17]. A recent Canadian population survey conﬁrmed the
high rates of treatment and control of hypertension [18].
At the end of the ﬁrst decade of the existence of
the CHEP, certain factors that became important for the
sustainability of the CHEP process became apparent and
may serve as a guide to implement such a program in other
regions or countries [19]. It needs a critical number of
experts in the ﬁeld to reduce individual bias and inﬂuence
in order to achieve an objective result which at the end
should be dictated by up-to-date evidence forming the
base of the recommendations and translating data from
trials and scientiﬁc studies into practical and applicable
recommendations. Before issued, consensus on the content
on wording of the recommendations has to be achieved.
It also includes the participation of interdisciplinary
health teams. In order to be applicable, recommendations
should be revised yearly as new information becomes rapidly
available. As the overseeing body, academic and governmentInternational Journal of Hypertension 3
organizations are involved, which is an important factor for
the integrity and credibility of the program. Although the
members of the CHEP are all volunteers, certain costs have
to be covered, and persistent ﬁnancial support is important
for the continuation of such a program.
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